Cantrell W, Lee P, Mendelsohn AM, Parno J, Rozzo SJ, Liao W. Efficacy and Safety of Tildrakizumab 100 Mg for Plaque Psoriasis in Patients Randomized to Treatment Continuation vs Treatment Withdrawal with Retreatment upon Relapse in Resurface 1. J of Skin [Internet]. 2020 Sep. 2 [cited 2024 Jul. 23];4(5):s40. Available from: https://jofskin.org/33014/index.php/skin/article/view/989